143 related articles for article (PubMed ID: 10074923)
1. Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone.
Murata J; Ayukawa K; Ogasawara M; Watanabe H; Saiki I
Int J Cancer; 1999 Mar; 80(6):889-95. PubMed ID: 10074923
[TBL] [Abstract][Full Text] [Related]
2. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
3. Impairment of the melanogenic pathway in B16 melanoma cells transfected with class I H-2 genes.
Prezioso JA; Hearing VJ; Muller J; Urabe K; Wang N; Gorelik E
Melanoma Res; 1995 Feb; 5(1):15-25. PubMed ID: 7734952
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the regulation of pigmentation in alpha-melanocyte-stimulating hormone responsive and unresponsive cultured B16 melanoma cells.
Hill SE; Buffey J; Thody AJ; Oliver I; Bleehen SS; Mac Neil S
Pigment Cell Res; 1989; 2(3):161-6. PubMed ID: 2549531
[TBL] [Abstract][Full Text] [Related]
5. Whitening activity of luteolin related to the inhibition of cAMP pathway in alpha-MSH-stimulated B16 melanoma cells.
Choi MY; Song HS; Hur HS; Sim SS
Arch Pharm Res; 2008 Sep; 31(9):1166-71. PubMed ID: 18806960
[TBL] [Abstract][Full Text] [Related]
6. Biochemical regulation of adenylate cyclase in murine melanoma clones with different metastatic properties.
Sheppard JR; Lester B; Doll J; Buscarino C; Gonzales E; Corwin S; Greig R; Poste G
Int J Cancer; 1986 May; 37(5):713-22. PubMed ID: 3009332
[TBL] [Abstract][Full Text] [Related]
7. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
Martínez-Esparza M; Solano F; García-Borrón JC
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D
Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.
Radinsky R; Beltran PJ; Tsan R; Zhang R; Cone RD; Fidler IJ
Cancer Res; 1995 Jan; 55(1):141-8. PubMed ID: 7805024
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
[TBL] [Abstract][Full Text] [Related]
11. Acteoside inhibits alpha-MSH-induced melanin production in B16 melanoma cells by inactivation of adenyl cyclase.
Song HS; Sim SS
J Pharm Pharmacol; 2009 Oct; 61(10):1347-51. PubMed ID: 19814867
[TBL] [Abstract][Full Text] [Related]
12. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
Wong W; Minchin RF
Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway.
Liu GS; Liu LF; Lin CJ; Tseng JC; Chuang MJ; Lam HC; Lee JK; Yang LC; Chan JH; Howng SL; Tai MH
Mol Pharmacol; 2006 Feb; 69(2):440-51. PubMed ID: 16269535
[TBL] [Abstract][Full Text] [Related]
14. The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells.
Smalley K; Eisen T
FEBS Lett; 2000 Jul; 476(3):198-202. PubMed ID: 10913613
[TBL] [Abstract][Full Text] [Related]
15. Linking αMSH with PPARγ in B16-F10 melanoma.
Maresca V; Flori E; Camera E; Bellei B; Aspite N; Ludovici M; Catricalà C; Cardinali G; Picardo M
Pigment Cell Melanoma Res; 2013 Jan; 26(1):113-27. PubMed ID: 22863076
[TBL] [Abstract][Full Text] [Related]
16. Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells.
Saiki I; Murata J; Yoneda J; Kobayashi H; Azuma I
Int J Cancer; 1994 Mar; 56(6):867-73. PubMed ID: 8119775
[TBL] [Abstract][Full Text] [Related]
17. alpha-Melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines.
Hedley SJ; Gawkrodger DJ; Weetman AP; Morandini R; Boeynaems JM; Ghanem G; Neil SM
Br J Dermatol; 1998 Mar; 138(3):536-43. PubMed ID: 9580817
[TBL] [Abstract][Full Text] [Related]
18. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells.
Kosano H; Setogawa T; Kobayashi K; Nishigori H
Life Sci; 1995; 56(20):1707-13. PubMed ID: 7723599
[TBL] [Abstract][Full Text] [Related]
19. Mansonone E from Mansonia gagei Inhibited α-MSH-Induced Melanogenesis in B16 Cells by Inhibiting CREB Expression and Phosphorylation in the PI3K/Akt Pathway.
Nishina A; Miura A; Goto M; Terakado K; Sato D; Kimura H; Hirai Y; Sato H; Phay N
Biol Pharm Bull; 2018; 41(5):770-776. PubMed ID: 29709914
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin-binding peptides interfere with melanocyte-stimulating hormone receptor activity and stimulate adenosine 3',5'-monophosphate production in M2R mouse melanoma cells.
Eshel Y; Salomon Y
Endocrinology; 1994 Jan; 134(1):177-85. PubMed ID: 8275931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
